|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
gptkb:PCV
gptkb:Hib
gptkb:IPV
gptkb:HepB
children
|
|
gptkbp:age
|
6 months
4-6 years
2 months
15-18 months
4 months
|
|
gptkbp:alternativeName
|
gptkb:DTPa
gptkb:DTPa_vaccine
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:associatedWith
|
gptkb:Tdap
gptkb:Td
DT
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:broadcastOn
|
5 doses
|
|
gptkbp:category
|
combination vaccine
pediatric vaccine
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
encephalopathy after previous dose
|
|
gptkbp:differenceFromDTwP
|
acellular pertussis component
|
|
gptkbp:firstLicensed
|
1990s
|
|
gptkbp:fullName
|
gptkb:Diphtheria,_Tetanus,_and_acellular_Pertussis_vaccine
|
|
gptkbp:hasComponent
|
diphtheria toxoid
tetanus toxoid
acellular pertussis antigens
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DTaP
|
|
gptkbp:includedIn
|
childhood immunization schedule
|
|
gptkbp:manufacturer
|
gptkb:Sanofi_Pasteur
GlaxoSmithKline
|
|
gptkbp:protectedBy
|
diphtheria
tetanus
pertussis
|
|
gptkbp:replacedBy
|
gptkb:DTwP
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
swelling at injection site
redness at injection site
mild fussiness
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:usedIn
|
gptkb:Canada
gptkb:Europe
gptkb:United_States
|
|
gptkbp:WHOStatus
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Pertussis
|
|
gptkbp:bfsLayer
|
5
|